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Abstract 
Background: With globalization and rapid urbanization, demographic and epidemiologic transitions have become important 
determinants for the emergence of  cardiovascular disease (CVD).
Objective: To estimate the prevalence of  CVD risk factors in adult out-patients attending general practice and non-specialist 
clinics in urban and rural Nigeria.
Methods: As part of  the Africa and Middle East Cardiovascular Epidemiological (ACE) study, a cross-sectional epidemiologic 
study was undertaken for the presence of  hypertension, diabetes mellitus, dyslipidemia, obesity, smoking and abdominal obesity 
in Nigeria.
Results: In total, 303 subjects from 8 out-patient general practice clinics were studied, 184 (60.7%) were female and 119 (39.3%) 
were male. Mean age was 42.7±13.1 years; 51.8% were aged <45 years; 4% ≥65 years. Over 90% of  subjects had ≥1 of  6 selected 
modifiable cardiovascular risk factors: 138 (45.6%) had 1-2; 65 (21.5%) had 3; 60 (19.8%) had 4; and 11 (3.6%) had 5 concurrent 
risk factors. Screening identified 206 subjects (68.0%) with dyslipidemia who did not have a prior diagnosis.
Conclusion: Cardiovascular risk factors are highly prevalent in Nigerian subjects attending out-patient clinics. Moreover, many 
subjects were undiagnosed and therefore unaware of  their cardiovascular risk status. Opportunistic screening alongside intensive 
national, multisectoral education or risk factor education is needed, should be scaled up nationwide and rolled out in both urban 
and rural communities in Nigeria.
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diovascular Epidemiological (ACE) study. 
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Background
Cardiovascular disease (CVD) has emerged in recent de-
cades as a major cause of  morbidity and mortality world-
wide1-3. An estimated 17-million deaths globally were due 
to CVD in 2002, and CVD or stroke are projected to be-
come the worldwide leading cause of  morbidity and mor-
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tality by 20203. This projection applies especially to low 
and middle-income countries, including Nigeria. Coun-
tries like Nigeria are undergoing major demographic tran-
sition associated with a progressive ageing population, as 
well as epidemiologic transition.
Throughout the 1950s and 1960s, hypertension was rel-
atively rare in African nations4, but in recent decades the 
prevalence has increased dramatically. For example, in a 
1979 Nigerian National Survey the prevalence of  hyper-
tension was approximately 11%, using a cut-off  for diag-
nosis of  blood pressure (BP) ≥160/95 mm Hg5. Using 
the conventional cut-off  (BP ≥140/90 mm Hg) preva-
lence was nearly 20% in a national survey carried out in 
2003 using a WHO step-wise questionnaire6. The rarity 
of  large vessel disease in West Africans has been attribut-
ed not only to a non-Western diet, but also to the bene-
ficial characteristics of  platelets which, unlike those of  
Europeans, easily undergo spontaneous disaggregation 
when aggregators are present, in addition to spontaneous 
rapid fibrinolysis7. According to Burkitt8, these protec-
tive advantages of  platelets are gradually being eroded by 
westernized lifestyles, and other practices, such as smok-
ing, lack of  exercise, urbanization and an excessive con-
sumption of  sugary drinks9. 
Furthermore, the advantages afforded by spontaneous 
disaggregation in Nigerians who have not adopted West-
ern lifestyles appear to be lost in Nigerians with diabetes 
mellitus10. Consequently, the emergence of  diabetes and 
other cardiovascular risk factors11, including the metabol-
ic syndrome12, together with coronary artery disease13-15, 
stroke16,17, cardiovascular morbidities and mortalities 
have become serious healthcare burdens in Nigeria18-20. 
As a result, systematic studies have been initiated along-
side adoption of  random risk factor screening program 
in healthcare clinics, in order to encourage healthier life-
styles in both rural and urban Nigerian communities. The 
Africa and Middle East Cardiovascular Epidemiological 
(ACE) Study21 was undertaken with the objective of  es-
timating the prevalence of  cardiovascular risk factors in 
out-patients attending general practice and non-specialist 




The ACE study (July 2011 to April 2012) was a cross-sec-
tional epidemiologic study (described in full elsewhere21). 
This post-hoc analysis of  ACE study data includes Nige-
rian subjects enrolled from January to February 2012 in 
general out-patient clinics of  the National Hospital Abu-
ja, University of  Abuja Teaching Hospital Gwagwala-
da, Calabar General Hospital Cross River State Calabar, 
University of  Nigeria Teaching Hospital Enugu, Federal 
Medical Centre Keffi Nassarawa State, General Hospital 
Akamkpa Cross River State and General Hospital Ak-
pabuyo Cross River State. These sites were chosen spe-
cifically to reflect both urban and rural populations21. The 
Nigerian study sites were part of  94 out-patient general 
practice clinics in 14 countries (2337 out-patients from 8 
African countries; 2041 out-patients from 6 Middle East-
ern countries21).
Subject selection was from a primary care setting situated 
in urban and rural areas seeing patients of  varied disease 
conditions and age groups. The rural populations are de-
fined as isolated (distance of  >50 km or lack of  easy ac-
cess to commuter transportation) from urban centers22. 
Although populations with a distance of  < 50 km from 
urban centres may be rural, such rural study sites were 
not part of  our study.
 
Study procedure
Eligibility criteria were confirmed and demographic data 
including date of  birth/age and gender were captured on 
a case report form (CRF). Medical history comprising all 
past/present diseases or syndromes that in the investi-
gator's judgment were considered to be clinically signifi-
cant with particular relevance to cardiovascular risk were 
recorded. Family history of  premature coronary heart 
disease (CHD) was considered as positive if  CHD oc-
curred in a male first-degree relative aged <55 years and/
or a female first-degree relative aged <65 years. CHD in-
cludes history of  myocardial infarction, unstable/stable 
angina, coronary artery procedures (angioplasty or bypass 
surgery) or evidence of  clinically significant myocardial 
ischemia.
All prior treatments administered for hypertension and 
dyslipidemia since diagnosis (if  available/applicable) were 
recorded on the CRF. Other previous treatments consid-
ered clinically relevant were also recorded.
Patients were classified as a current smoker (consumed 
any cigarettes or tobacco, or used other forms of  nico-
tine such as snuff, chewing tobacco, or any other local 
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nicotine product during the past year), never smoked or 
ex-smoker. Age at smoking the first cigarette/nicotine 
product, number of  cigarettes/nicotine products used 
per day and, if  ex-smoker, when patient ceased smoking, 
were also recorded.
Patients were weighed, when wearing light clothing, us-
ing a calibrated scale and recorded to the nearest 0.1 kg. 
The scale’s zero value was checked daily. Patient’s height 
was measured with a height meter , where the patient re-
moved his/her footwear and remained standing, with feet 
together on a horizontal, flat surface and heels, calves, 
glutei, spine and head in contact with the vertical edge 
of  the height meter. The head was positioned such that 
the external auditory meatus and the external edge of  the 
orbit formed a horizontal line. The movable part of  the 
height meter was lowered toward the patient’s head until 
it touched the top of  the head. The patient then care-
fully moved away, and corresponding measurement was 
recorded to the nearest 0.5 cm.
Body mass index (BMI) (weight (kg)/[height in meters]2) 
was derived from the patient’s measurements. A BMI 
≥30kg/m2 was classified as obesity. Waist circumference 
was measured halfway between the inferior margin of  
the last rib and the crest of  the ileum in the mid-axillary 
plane. Waist circumference was used to define abdominal 
obesity (men ≥ 94 cm, women ≥ 80 cm based on IDF 
consensus)23.
Arterial BP was determined after the patient had been 
sitting quietly for 5 minutes, using a standardized BP 
measuring instrument. Diastolic BP coincided with the 
phase V (disappearance of  Korotkoff  sound). BP was the 
average of  two consecutive measurements, taken once on 
each arm. BP ≥140/90 mmHg was classified as hyperten-
sion. Heart rate was estimated by taking the radial artery 
pulse for 1 minute, after each arterial BP measurement. 
BP readings were classified according to the European 
Society of  Cardiology (ESC) Guidelines24. Patients re-
ceiving BP-regulating drugs at the time of  the study were 
classified as hypertensive regardless of  the BP levels.
Fasting total cholesterol, high-density lipoprotein cho-
lesterol (HDL-C), low-density lipoprotein cholesterol 
(LDL-C) and triglycerides were classified according to 
the US National Cholesterol Education Program Adult 
Treatment Panel (NCEP ATP) III Guidelines25. Fasting 
plasma glucose was classified per American Diabetes As-
sociation (ADA) guidelines26. Hence, six modifiable risk 
factors including dyslipidemia, hypertension, diabetes, 
smoking, BMI and abdominal obesity were determined.
Subjects could withdraw from the study at any time, or 
they could be withdrawn at any time at the discretion 
of  the investigator or sponsor for safety, behavioral or 
administrative reasons. If  a subject did not return for a 
scheduled visit (i.e. blood draws at laboratory), every ef-
fort was made to contact the subject and document sub-
ject outcome. The investigator enquired about the reason 
for withdrawal, requested the subject to return for a fi-
nal visit, if  applicable, and followed-up with the subject 
regarding any unresolved adverse events. Subjects who 
withdrew and also withdrew consent had no further eval-
uations, and no additional data were collected. All study 
data were captured in a paper CRF.
 
Inclusion and exclusion criteria
The full methodology for the ACE study has been re-
ported elsewhere21. Male or female subjects aged >18 
years who signed and dated the informed consent doc-
ument were included while subjects who presented with 
any life-threatening disease/condition as well as pregnant 
women and/or lactating mothers were excluded.
 
Sample size and sampling method
A total of  303 subjects were enrolled into the ACE study 
from Nigeria, and 301 completed. Participants were a 
subset of  the multi-country ACE sample size which was 
determined by assuming that >90% of  enrolled subjects 
contribute to the primary analyses, percentage of  subjects 
with dyslipidemia and percentage of  subjects with hyper-
tension. The ACE study had a planned total sample size 
of  4300 subjects which permits the estimation of  these 
percentages to within ± 1.6% with 95% confidence; i.e. 
the half-width of  the 95% confidence interval (CI) will 
be 1.6 or less21. A minimum of  150 subjects were en-
rolled per country to obtain a sample size sufficient for 
exploring the primary endpoint within sub-groups (coun-
try, urban vs rural, age, etc.). Enrolment per country had a 
maximum number of  subjects determined by the health-
care infrastructure and ability to provide subjects, based 
on pre-study feasibility assessment. In the full ACE study 
and this sub-analysis, every fifth patient seen on a partic-
ular day, fulfilling the inclusion and exclusion criteria, was 
included in the study.
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Data analysis
Analyses were primarily descriptive in nature. Binary data 
were summarized using the percent of  subjects with the 
event and a 95% CI. Continuous data were reported us-
ing n, mean, standard deviation, median and range; a 95% 
CI for the mean was also computed. No interim analyses 
were planned. All statistical tests were two-sided and con-
ducted at the 0.05 level of  significance. P-values ≤0.05 
were considered statistically significant. No adjustments 
for multiple testing were undertaken.
 
Ethical approval
Approval of  the ACE study protocol, protocol amend-
ments and informed consent forms were obtained from 
the IRB/IEC as reported elsewhere21. The study was 
conducted in accordance with the Declaration of  Helsin-
ki on Ethical Principles for Medical Research Involving 
Human Subjects, adopted by the General Assembly of  
the World Medical Association (1996).
In addition, the study was conducted in accordance with 
the protocol, the International Conference on Har-
monisation (ICH) guidelines on Good Clinical Practice 
(GCP), and applicable local regulatory requirements and 
laws. Protection of  subject personal data was ensured and 
subject names were not included on any sponsor forms, 
reports, publications or in any other disclosures, except 
where required by laws. The informed consent form was 
in compliance with ICH GCP, local regulatory and legal 
requirements. The investigators ensured that each sub-
ject, or his/her legally acceptable representative, was fully 
informed about the nature and objectives of  the study 
and possible risks21. The investigators obtained written, 
informed consent from each subject or the subject’s le-





A total of  303 subjects (184 females [60.7%] and 119 
males [39.3%]) from 8 out-patient general practice clinics 
in Nigeria were enrolled; 92 (30.4%) of  the total cohort 
were enrolled from centers in rural communities. The 
mean age was 42.7 (± 13.1) years; about half  (51.8%) 
were aged <45 years and only 12 (4%) were 65 years or 
older (Table 1). Overall, 138 subjects (45.5%) had 1-2 of  
the 6 modifiable cardiovascular risk factors measured. 65 
(21.5%) had 3 risk factors; 19.8% had 4 risk factors, and 
3.6% had 5 concurrent risk factors (Figure 1).
 
Figure 1: Proportion of out-patients presenting with one or more cardiovascular risk 
factors cardiovascular risk factors captured are: dyslipidemia, hypertension, obesity 
(defined as BMI ≥30 kg/m2), abdominal obesity, diabetes and smoking. 
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Variable Total cohort  (N=303) Males (n=119) Females (n=184) 
Age n (%)     
18–44 years 157 (51.8) 67 (56.3) 90 (48.9) 
45–64 years 134 (44.2) 48 (40.3) 86 (46.7) 
≥65 years 12 (4.0) 4 (3.4) 8 (4.3) 
Mean years 
(range) 42.7 (18.0–85.0) 42.6 (19.0–85.0) 42.8 (18.0–82.0) 
Rural 92 (30.4) 35 (38.0) 57 (62.0) 
Urban 211 (69.6) 84 (39.8) 127 (60.2) 
Median Systolic blood 
pressure 
 (mm Hg) 
132.0 (120.0, 145.0) 136.0 (120.0, 146.0) 130.0 (120.0, 144.0) 
Median Diastolic 
blood pressure  
(mm Hg) 
82.0 (74.0, 91.0) 86.0 (74.0, 93.0) 80.0 (74.0, 90.0) 
Median Waist 
circumference (cm) 90.0 (82.8, 98.8) 88.5 (82.8, 96.5) 91.5 (82.2, 101.3) 
Median BMI (kg/m2) 25.9 (23.0, 29.8) 24.7 (22.7, 28.1) 27.1 (23.4, 30.7) 
Median Total 
cholesterol (mg/dL) 180.7 (154.4, 209.1) 175.5 (154.4, 204.6) 185.3 (162.2, 212.4) 
Median LDL-C 
(mg/dL) 114.0 (86.1, 139.0) 108.1 (79.2, 135.1) 116.3 (94.1, 140.9) 
Median HDL-C 
(mg/dL) 42.5 (33.9, 55.0) 42.5 (30.9, 56.1) 45.0 (34.7, 54.1) 
Median Triglycerides 




4.8 (4.2, 5.6) 4.8 (4.1, 5.4) 4.9 (4.2, 5.8) 
Data are mean (%) or median (25th, 75th percentile) unless otherwise indicated. BMI: body mass index; LDL-C: 
low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol. 
 
Table 1: Baseline parameters across the total Nigerian cohort 
and male and female populations 
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Dyslipidemia: prevalence
Dyslipidemia was the most prevalent cardiovascular risk 
factor recorded in 71.1% of  298 participants analysed 
(Figure 2). Median lipid values are given in Table 1. The 
most frequent type of  dyslipidemia was low HDL-C, 
which was recorded in 117 participants (39%). Of  the 
303 enrolled subjects, 6 (2.0%) were diagnosed with dys-




Elevated BP was recorded in 43.9% of  301 adult outpa-
tients analyzed (Figure 2), where 114 had a prior history 
of  hypertension and an additional 18 were found to have 
an abnormal BP reading at study encounter. Median sys-
tolic/diastolic BP was 132/82 mm Hg (Table 1). Of  the 
303 enrolled subjects, approximately one out of  every 17 
out-patients screened were found to have an elevated BP 
that was not known before (18 out-patients; 5.9%). 
 
Obesity: prevalence
Median (25th, 75th percentile) waist circumference was 
88.5 cm (82.8-96.5) in men and 91.5 cm (82.2-101.3) in 
women, and median BMI was 25.9 kg/m2 (Table 1). The 
prevalence of  obesity  when defined by waist circumfer-
ence (i.e., abdominal obesity), was appropriately 2.5 times 
more common than the prevalence of  obesity when de-
fined by BMI ≥30 kg/m2 (63.7% vs. 24.4% respectively) 
(Figure 2). Approximately 2 out of  3 out-patients screened 
had abdominal obesity (193 out-patients; 63.7%), and ~1 
out of  every 4 out-patients screened had obesity (defined 
by BMI ≥30 kg/m2) (74 out-patients; 24.4%).
 
Diabetes: prevalence
Approximately one-fifth of  280 adult out-patients ana-
lyzed had diabetes (Figure 2), with 40 of  the 303 enroll-
ees (13.2%) having a prior diagnosis and an additional 20 
(6.6%) were diagnosed with an abnormal blood glucose 
level of   ≥7 mmol/L. Out of  the 303 enrolled subjects, 
approximately 1 out of  15 out-patients screened were 
newly diagnosed with diabetes (20 out-patients; 6.6%).
Smoking: prevalence
The prevalence of  current smoking was 2.3% of  303 sub-
jects analyzed (6.3% past smokers) (Figure 2).
Figure 2: Overall prevalence of cardiovascular risk factors across Nigeria 
Graph to show the overall prevalence of dyslipidemia, hypertension, obesity  
(defined as BMI ≥30 kg/m2), abdominal obesity, diabetes and smoking across Nigeria 
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Prevalence of  risk factors by age, gender and com-
munity (urban vs. rural)
Older out-patients had higher rates of  dyslipidemia, hy-
pertension, and diabetes, while approximately 1/2 of  the 
younger out-patients aged <40 years had dyslipidemia or 
abdominal obesity (Figure 3). 
 
 
Figure 3: Prevalence of cardiovascular risk factors by age group 
Male and females had similar prevalences of  dyslipid-
emia, hypertension and diabetes but females had a higher 
prevalence of  obesity and abdominal obesity. Smoking 
was more common in males (Figure 4).
 
 
Figure 4: Prevalence of cardiovascular risk factors by gender 
The prevalence rates of  most of  the cardiovascular risk 
factors measured were higher in rural centers. Urban cen-
ters also demonstrate high rates of  dyslipidemia (69.9%), 
hypertension (41.2%), diabetes (18.7%) and abdominal 
obesity (62.6%). Smoking prevalance was similar between 
rural and urban communities (Figure 5).
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Figure 5: Prevalence of cardiovascular risk factors in rural and urban communities 
Discussion
Primary prevention, early detection and prompt, effective 
control as well as health promotion strategies are critical 
in the attempt to reverse the global burden of  CVD27,28. 
This cross-sectional study of  Nigerian out-patients re-
vealed a low prevalence of  smoking (2.3%), but it im-
portantly highlights the high prevalence of  hypertension 
(43.9%) and the more alarmingly, the high prevalence of  
dyslipidemia (71.1%), most frequently associated with 
low HDL-C in almost 39% of  patients. Furthermore, we 
report that obesity, defined either by BMI (24.4%) or in 
particular by abdominal circumference (63.7%) was also 
highly prevalent, possibly suggesting poor nutrition or an 
inadequate exercise culture among these Nigerian out-pa-
tients. Reorganization of  the Nigerian food-pyramid, 
together with a national exercise incentive program may 
aid reducing the prevalence of  obesity, targeting every-
where from homes to schools. Obesity and being over-
weight have been documented to start early in Nigerian 
pre-school and school children30,31, thus prompting the 
extension of  control measures to age groups below those 
of  the adult population in this study. Such a radical plan 
would need to be implemented by a multisectoral, mul-
tidisciplinary team involving communities, for example 
the Nigerian Labour Congress, women’s organizations or 
religious groups29,30.
Dyslipidemia was also reported in more than two-thirds 
of  adult out-patients in this cross-sectional study. The im-
portance of  reducing LDL-C levels by nutritional modifi-
cation, exercise and careful deployment of  statins cannot 
therefore be over-emphasized. Several studies in Nigeria 
have shown the presence of  dyslipidemia in Nigerian pa-
tients with diabetes31-33 presenting with hypertension34 and 
in apparently normal health professionals35,36. The pres-
ent study reveals the risk factors of  obesity, hypertension, 
diabetes and dyslipidemia in not only young and old out-
patients, both male and female, but also in out-patients 
in rural and urban areas where the rural–urban gap in 
obesity levels has narrowed and may, in some areas, have 
disappeared. Obesity remains more common in female 
Nigerian subjects attending adult general out-patient clin-
ics however, perhaps pointing to inadequate post-natal 
exercise in Nigerian women.
The smoking prevalence was notably low in the present 
study of  adult out-patients, aged 18 years and over. Al-
though this is a positive finding it is somewhat in contrast 
to a global youth tobacco survey (GYTS) in 2008 in Ni-
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geria which revealed a worryingly high prevalence of  to-
bacco use among youths (boys and girls) – a serious phe-
nomenon requiring aggressive intervention37. Smoking 
prevention and cessation guidelines in Africa and Middle 
East have been prepared and published38, and may have 
contributed to fewer adults continuing to smoke as found 
in our study.
Our study focused on six cardiovascular risk factors; mul-
tiple risk factors were found to be clustered in individuals, 
for example two risk factors in 22.8% of  the subjects; 
three risk factors in 21.5%; four risk factors in 19.8%; and 
five risk factors in 3.6%. Our observations suggest bet-
ter supervision and care of  these risk factors are needed, 
particularly when they are found clustered in one individ-
ual. Without a concerted, multi-factorial approach with 
deliberate lifestyle modifications, an increase in tangible 
and intangible costs, deleterious effect on quality of  life, 
and a heavier burden on national health infrastructures 
will occur. For example, the nationwide, Diabcare Nigeria 
Study (2008) demonstrated serious gaps in co-operation 
between patients and commitment from caregivers, with 
regard to meeting recommended targets for lipid, blood 
glucose, weight and BP, despite effective pharmacologic 
interventions and use of  statins39. These collective obser-
vations highlight the importance of  urgent, mandatory 
implication and adherence to international guidelines on 
cardiovascular disease management 25,26,40.
Comprehensive screening for risk factors in a large Nige-
rian population is, logistically and infrastructurally, a Her-
culean task; therefore, opportunistic screening, national 
and cultural education, mobilization of  health-seeking 
attitudes and behavior throughout the population, along-
side widespread implementation of  WHO recommended 
surveillance41,42 of  risk factors, are needed. National risk 
factor education is very important and should be main-
tained so that every teenager and adult knows his/her BP, 
weight, cholesterol, genotype and blood sugar level43, de-
spite the socio-cultural complexities of  such a venture44. 
Various screening studies in rural and urban Nigerian set-
tings45-47 including house-to-house screening, as in Abia 
state NCD project48,49, have shown that these risk factors 
occur in both urban and rural areas; the old dichotomy is 
disappearing and may have in fact disappeared, as report-
ed in South Africa50. 
Even though income levels may create a barrier to screen-
ing programs51,52, because cost pressures will limit access, 
the use of  primary healthcare centers is recommended. 
In a primary healthcare setting, high rates of  physical in-
activity (81.6%), diabetes (7.7%) and asymptomatic hy-
pertension (26.4%) have been reported by others53, while 
among rural Fulani in Northern Nigeria, impaired fasting 
glucose (6.9%), impaired glucose tolerance (8%) and the 
effect of  advancing age and obesity were observed53. In 
addition, the importance of  screening young, pre-school 
and adolescents, in whom risk factors have been docu-
mented in Nigeria55, cannot be over-emphasized. It is im-
portant to note that this study was conducted in selected 
rural and urban hospital settings and the findings may not 
be generalized to the general population.  
Conclusion
Cardiovascular risk factors are highly prevalent in adults 
attending general out-patient clinics in Nigeria, many of  
whom were undiagnosed and therefore unaware of  their 
cardiovascular risk status prior to screening. We recom-
mend that opportunistic cardiovascular disease risk factor 
screening alongside intensive national, multisectoral car-
diovascular education needs to be implemented, scaled 
up nationwide, and rolled out in both urban and rural 
communities in Nigeria.
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